These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1254108)

  • 1. Department of Medicina, Faculdade de Medicina da Universidade de São Paulo, Brazil.
    Pupo AA; Ursich MJ; Iamaguchi E; Vasconcellos FG
    Diabetes; 1976 Mar; 25(3):161-6. PubMed ID: 1254108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dynamics of insulin secretion in dogs with alloxan diabetes].
    Dagaeva LN; Belikova FS; Podotykina OI; Makarova AV
    Biull Eksp Biol Med; 1978 Mar; 85(3):278-81. PubMed ID: 352428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for direct action of alloxan to induce insulin resistance at the cellular level.
    Ader M; Richey JM; Bergman RN
    Diabetologia; 1998 Nov; 41(11):1327-36. PubMed ID: 9833941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon suppression improves glucoregulation in moderate but not chronic severe diabetes.
    Lickley HL; Kemmer FW; Doi K; Vranic M
    Am J Physiol; 1983 Oct; 245(4):E424-9. PubMed ID: 6137957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose turnover in the exercising dog with chemically induced diabetes and the effect of methylprednisolone.
    Issekutz B; Shaw WA
    Diabetes; 1975 Oct; 24(10):915-21. PubMed ID: 126184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Bordetella pertussis vaccine on glucagon secretion in normal and alloxan dogs.
    Nakamura Y; Yoshida T; Osumi T; Araki Y; Kondo M
    Endocrinol Jpn; 1980 Oct; 27(5):585-91. PubMed ID: 7016512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of adenosine cyclic monophosphate on insulin secretion in healthy rats and in those with alloxan diabetes].
    Kniazev IuA; Vakhrusheva LL; Golovanova VB; Zheltukov NS
    Probl Endokrinol (Mosk); 1980; 26(3):53-5. PubMed ID: 6250140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal B-cell function in neonatally streptozotocin-diabetic rats: insensitivity to alloxan toxicity.
    Grill V; Westberg M
    Endocrinology; 1987 Dec; 121(6):2171-6. PubMed ID: 2445559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metasomatotrophic diabetes and its induction: basal insulin secretion and insulin release responses to glucose, glucagon, arginine and meals.
    Pierluissi J; Campbell J
    Diabetologia; 1980 Mar; 18(3):223-8. PubMed ID: 6989696
    [No Abstract]   [Full Text] [Related]  

  • 10. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H; Dobbs R; Unger RH
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of an algorithm for the artificial B-cell using the normal insulin-glucose relationship in diabetic dogs and men.
    Fischer U; Jutzi E; Bombor H; Freyse EJ; Salzieder E; Albrecht G; Besch W; Bruns W
    Diabetologia; 1980; 18(2):97-107. PubMed ID: 6988280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preventive effect of bombesin on alloxan-induced diabetes in rat].
    Song Y; Yu JR
    Sheng Li Xue Bao; 1991 Oct; 43(5):428-35. PubMed ID: 1796306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of glucagon in mediating epinephrine-induced hyperglycemia in alloxan-diabetic dogs.
    Perez G; Kemmer FW; Lickley HL; Vranic M
    Am J Physiol; 1981 Oct; 241(4):E328-35. PubMed ID: 7032319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevailing hyperglycemia is critical in the regulation of glucose metabolism during exercise in poorly controlled alloxan-diabetic dogs.
    Christopher MJ; Rantzau C; McConell G; Kemp BE; Alford FP
    J Appl Physiol (1985); 2005 Mar; 98(3):930-9. PubMed ID: 15703164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
    Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
    Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of glucose turnover in the pathophysiology of diabetes: an in vivo analysis in diabetic dogs.
    Fisher SJ; Lekas MC; McCall RH; Shi ZQ; Giacca A; Vranic M
    Diabetes Metab; 1996 Apr; 22(2):111-21. PubMed ID: 8792091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic effects of dexfenfluramine on glucose and insulin response to intravenous glucose in diabetic and non-diabetic obese subjects.
    Glaser B; Raveh Y; Norynberg C; Berry E; Lavielle R; Nathan C; Cerasi E
    Diabetes Res; 1992; 19(4):165-76. PubMed ID: 1343113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus.
    Kosaka K; Kuzuya T; Hagura R; Yoshinaga H
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S109-19. PubMed ID: 8894494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of subbasal insulin infusion on resting and exercise-induced glucose turnover in depancreatized dogs.
    Shi ZQ; Giacca A; Yamatani K; Fisher SJ; Lickley HL; Vranic M
    Am J Physiol; 1993 Mar; 264(3 Pt 1):E334-41. PubMed ID: 8460681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central prolactin modulates insulin sensitivity and insulin secretion in diabetic rats.
    Park S; Kang S; Lee HW; Ko BS
    Neuroendocrinology; 2012; 95(4):332-43. PubMed ID: 22441304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.